We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4B
AUM Growth
-$1.11B
Cap. Flow
-$117M
Cap. Flow %
-0.67%
Top 10 Hldgs %
25.42%
Holding
3,045
New
14
Increased
313
Reduced
2,663
Closed
30

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.3M
2
NVDA icon
NVIDIA
NVDA
+$38.8M
3
AAPL icon
Apple
AAPL
+$36.4M
4
WSM icon
Williams-Sonoma
WSM
+$21.8M
5
EXE
Expand Energy Corp
EXE
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Financials 13.87%
3 Consumer Discretionary 10.73%
4 Healthcare 10.45%
5 Industrials 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSVN icon
2576
Bank7 Corp
BSVN
$523M
$76.3K ﹤0.01%
1,970
-29
-1% -$1.21K
SAMG icon
2577
Silvercrest Asset Management
SAMG
$77.8M
$76.3K ﹤0.01%
4,661
-69
-1% -$1.23K
VYGR icon
2578
Voyager Therapeutics
VYGR
$197M
$76.2K ﹤0.01%
22,537
-333
-1% -$1.56K
CHMG icon
2579
Chemung Financial Corp
CHMG
$410M
$76.1K ﹤0.01%
1,600
-24
-1% -$1.18K
FULC icon
2580
Fulcrum Therapeutics
FULC
$290M
$76K ﹤0.01%
26,381
-4,469
-14% -$16.4K
TBI
2581
Trueblue
TBI
$266M
$75.8K ﹤0.01%
14,275
-211
-1% -$1.44K
HUMA icon
2582
Humacyte
HUMA
$158M
$75.6K ﹤0.01%
44,317
+615
+1% +$2.31K
OPRX icon
2583
OptimizeRx
OPRX
$137M
$75.5K ﹤0.01%
8,719
-15
-0.2% -$92
ATLO icon
2584
AMES National
ATLO
$288M
$75.4K ﹤0.01%
4,305
-63
-1% -$1.13K
OLMA icon
2585
Olema Pharmaceuticals
OLMA
$894M
$75.3K ﹤0.01%
20,026
-296
-1% -$1.49K
NKSH icon
2586
National Bankshares
NKSH
$273M
$75K ﹤0.01%
2,818
-42
-1% -$1.18K
ESCA icon
2587
Escalade
ESCA
$269M
$75K ﹤0.01%
4,899
-73
-1% -$1.1K
WTI icon
2588
W&T Offshore
WTI
$620M
$74.9K ﹤0.01%
48,322
-717
-1% -$1.18K
LZM icon
2589
Lifezone Metals
LZM
$353M
$74.8K ﹤0.01%
17,889
-265
-1% -$1.48K
BROS icon
2590
Dutch Bros
BROS
$6.06B
$74.8K ﹤0.01%
1,211
-44
-4% -$2.9K
ROKU icon
2591
Roku
ROKU
$23B
$74.7K ﹤0.01%
1,060
-36
-3% -$2.88K
PNRG icon
2592
PrimeEnergy Resources
PNRG
$334M
$74.5K ﹤0.01%
327
-12
-4% -$2.48K
GLOB icon
2593
Globant
GLOB
$1.63B
$74.3K ﹤0.01%
631
-24
-4% -$4.3K
PRTH icon
2594
Priority Technology Holdings
PRTH
$490M
$74.1K ﹤0.01%
10,876
+1,733
+19% +$16.4K
DH icon
2595
Definitive Healthcare
DH
$112M
$74K ﹤0.01%
25,620
-890
-3% -$3.61K
ECG
2596
Everus Construction Group
ECG
$6.1B
$73.7K ﹤0.01%
1,988
-162
-8% -$8.72K
FLWS icon
2597
1-800-Flowers.com
FLWS
$194M
$73.5K ﹤0.01%
12,461
-184
-1% -$1.35K
LNKB
2598
DELISTED
LINKBANCORP
LNKB
$73.5K ﹤0.01%
10,842
-161
-1% -$1.16K
RMAX
2599
DELISTED
RE/MAX Holdings
RMAX
$73.4K ﹤0.01%
8,767
-130
-1% -$1.24K
RSVR
2600
Reservoir Media
RSVR
$624M
$72.8K ﹤0.01%
9,539
-141
-1% -$1.11K

Similar funds

Corebridge Financial's Q1 2025 Portfolio in Review

As of Q1 2025, Corebridge Financial held 3,045 positions worth $17.4B, down 6% from $18.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 1.4%. Corebridge Financial opened 14 new positions and exited 30, leaving the 3,045-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q1 2025 buy was State Street Blackstone Senior Loan ETF: 9,585,037 shares worth $394M.
  • Corebridge Financial added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2025, an estimated $19.5M increase.
  • Corebridge Financial's biggest Q1 2025 reduction was Microsoft, cutting an estimated $39.3M.
  • Corebridge Financial fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $10.6M.
  • Corebridge Financial's ten largest holdings make up 25% of its $17.4B portfolio in Q1 2025.
  • Corebridge Financial opened 14 new positions and closed 30 in Q1 2025.
  • Corebridge Financial's portfolio value fell 6% quarter-over-quarter to $17.4B.

Based on Corebridge Financial's 13F filing for Q1 2025, filed 14 May 2025.